Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417.
Schefter TE, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W Jr, Gaffney DK. Schefter TE, et al. Among authors: stuhr k. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1179-84. doi: 10.1016/j.ijrobp.2011.10.060. Epub 2012 Feb 16. Int J Radiat Oncol Biol Phys. 2012. PMID: 22342094 Clinical Trial.
Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas.
Schwer AL, Kavanagh BD, McCammon R, Gaspar LE, Kleinschmidt-De Masters BK, Stuhr K, Chen C. Schwer AL, et al. Among authors: stuhr k. Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1352-7. doi: 10.1016/j.ijrobp.2008.06.1919. Epub 2008 Nov 14. Int J Radiat Oncol Biol Phys. 2009. PMID: 19013723 Clinical Trial.
Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
Chen C, Damek D, Gaspar LE, Waziri A, Lillehei K, Kleinschmidt-DeMasters BK, Robischon M, Stuhr K, Rusthoven KE, Kavanagh BD. Chen C, et al. Among authors: stuhr k. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1066-74. doi: 10.1016/j.ijrobp.2010.07.021. Epub 2010 Oct 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20932651 Clinical Trial.
RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
Schefter T, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W Jr, Sause W, Gaffney D; Radiation Therapy Oncology Group (RTOG). Schefter T, et al. Among authors: stuhr k. Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):101-5. doi: 10.1016/j.ijrobp.2013.10.022. Int J Radiat Oncol Biol Phys. 2014. PMID: 24331655 Clinical Trial.
Practical implementation of quality improvement for high-dose-rate brachytherapy.
Schubert L, Liu A, Gan G, Amini A, Hutchison R, Ernest J, Thornton D, Stoehr S, Hinman B, Stuhr K, Westerly D, Schefter T, Fisher C. Schubert L, et al. Among authors: stuhr k. Pract Radiat Oncol. 2016 Jan-Feb;6(1):34-43. doi: 10.1016/j.prro.2015.09.003. Epub 2015 Sep 18. Pract Radiat Oncol. 2016. PMID: 26577008
43 results